CU22695A1 - Formulación para la estimulación de la síntesis del pigmento melánico - Google Patents
Formulación para la estimulación de la síntesis del pigmento melánicoInfo
- Publication number
- CU22695A1 CU22695A1 CU1998110A CU1998110A CU22695A1 CU 22695 A1 CU22695 A1 CU 22695A1 CU 1998110 A CU1998110 A CU 1998110A CU 1998110 A CU1998110 A CU 1998110A CU 22695 A1 CU22695 A1 CU 22695A1
- Authority
- CU
- Cuba
- Prior art keywords
- treatment
- skin
- synthesis
- composition
- pigment
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000015572 biosynthetic process Effects 0.000 title abstract 3
- 239000000049 pigment Substances 0.000 title abstract 3
- 238000003786 synthesis reaction Methods 0.000 title abstract 3
- 230000000638 stimulation Effects 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title 1
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 4
- 210000003491 skin Anatomy 0.000 abstract 3
- 206010047642 Vitiligo Diseases 0.000 abstract 2
- 206010067482 No adverse event Diseases 0.000 abstract 1
- 230000035614 depigmentation Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000002427 irreversible effect Effects 0.000 abstract 1
- 210000002752 melanocyte Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000037311 normal skin Effects 0.000 abstract 1
- 230000000144 pharmacologic effect Effects 0.000 abstract 1
- 238000007086 side reaction Methods 0.000 abstract 1
- 230000003192 teratological effect Effects 0.000 abstract 1
- 230000002110 toxicologic effect Effects 0.000 abstract 1
- 231100000027 toxicology Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
- A61K8/982—Reproductive organs; Embryos, Eggs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/04—Preparations for care of the skin for chemically tanning the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Developmental Biology & Embryology (AREA)
- Dermatology (AREA)
- Cell Biology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pregnancy & Childbirth (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Birds (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención se relaciona con la rama de la Medicina Humana, y dentro de ella con la Dermatología, y en particular con una composición desarrollada para la estimulación de la síntesis del pigmento melánico de la piel, y por lo tanto útil en el tratamiento del vitiligo. El objetivo técnico de la presente invención es proporcionar una composición de un producto de origen natural útil en el tratamiento del vitiligo, el cual no posee efectos tóxicos y no recidiva de la enfermedad. La composición obtenida estimula la síntesis del pigmento melánico de la piel y la reproducción de los melanocitos según se demostró en los ensayos farmacológicos a que fue sometido, careciendo totalmemte de reacciones secundarias severas como demuestran los ensayos toxicológicos, teratológicos y clínicos realizados. El producto obtenido es de fácil obtención y aplicación, el efecto repigmentante comienza rápidamente después de iniciar el tratamiento, siendo irreversible al descontinuar su aplicación. El color adquirido es identico al de las áreas de la piel normal del paciente, las cuales a su vez no incrementan posteriormente la intensidad de su coloración. El producto obtenido puede también ser empleado para el tratamiento cualquier proceso de despigmentación de la piel, por ejemplo aquel que se produce debido a las quemaduras.
Priority Applications (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998110A CU22695A1 (es) | 1998-07-28 | 1998-07-28 | Formulación para la estimulación de la síntesis del pigmento melánico |
| ARP990103684A AR029307A1 (es) | 1998-07-28 | 1999-07-27 | Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion |
| HK01106963.9A HK1037520B (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating the synthesis of the melanic pigment and procedure to obtain it |
| PCT/CU1999/000003 WO2000006180A1 (es) | 1998-07-28 | 1999-07-28 | Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion |
| DE69922662T DE69922662D1 (de) | 1998-07-28 | 1999-07-28 | Zusammensetzung zur stimulierung der melaninpigment-synthese und verfahren zu deren herstellung |
| MXPA01001014A MXPA01001014A (es) | 1998-07-28 | 1999-07-28 | Composicion para la estimulacion de la sintesis del pigmento melanico y procedimiento para su obtencion. |
| JP2000562034A JP2002521453A (ja) | 1998-07-28 | 1999-07-28 | メラニン色素の合成を刺激する組成物およびその製造方法 |
| HU0103274A HUP0103274A2 (hu) | 1998-07-28 | 1999-07-28 | A melanin pigment szintézisét stimuláló készítmény és eljárás előállítására |
| EP99934451A EP1101494B1 (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating the synthesis of the melanic pigment and procedure to obtain it |
| CNB99810745XA CN1187059C (zh) | 1998-07-28 | 1999-07-28 | 刺激黑色素合成的组合物及其制备方法 |
| CA002336526A CA2336526A1 (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating the synthesis of the melanic pigment and process for obtaining it |
| RU2001105539/15A RU2225716C2 (ru) | 1998-07-28 | 1999-07-28 | Композиция для стимуляции синтеза меланинового пигмента и способ ее получения |
| UA2001010624A UA63015C2 (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating synthesis of melanic pigment, method for its production and method for treating vitiligo |
| AT99934451T ATE284699T1 (de) | 1998-07-28 | 1999-07-28 | Zusammensetzung zur stimulierung der melaninpigment-synthese und verfahren zu deren herstellung |
| US09/744,633 US6660305B1 (en) | 1998-07-28 | 1999-07-28 | Composition for stimulating the synthesis of the melanic pigment and process for obtaining it |
| BR9913345-8A BR9913345A (pt) | 1998-07-28 | 1999-07-28 | Composição para a estimulação da sìntese do pigmento melânico e procedimetno para a sua obtenção |
| BG105208A BG105208A (en) | 1998-07-28 | 2001-01-31 | Composition for stimulating the synthesis of the melanic pigment and process for obtaining it |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1998110A CU22695A1 (es) | 1998-07-28 | 1998-07-28 | Formulación para la estimulación de la síntesis del pigmento melánico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22695A1 true CU22695A1 (es) | 2001-07-31 |
Family
ID=5459380
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1998110A CU22695A1 (es) | 1998-07-28 | 1998-07-28 | Formulación para la estimulación de la síntesis del pigmento melánico |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6660305B1 (es) |
| EP (1) | EP1101494B1 (es) |
| JP (1) | JP2002521453A (es) |
| CN (1) | CN1187059C (es) |
| AR (1) | AR029307A1 (es) |
| AT (1) | ATE284699T1 (es) |
| BG (1) | BG105208A (es) |
| BR (1) | BR9913345A (es) |
| CA (1) | CA2336526A1 (es) |
| CU (1) | CU22695A1 (es) |
| DE (1) | DE69922662D1 (es) |
| HU (1) | HUP0103274A2 (es) |
| MX (1) | MXPA01001014A (es) |
| RU (1) | RU2225716C2 (es) |
| UA (1) | UA63015C2 (es) |
| WO (1) | WO2000006180A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100421660C (zh) * | 2003-08-05 | 2008-10-01 | 胎盘组织治疗中心 | 治疗白癜风的组合物 |
| CN101605566A (zh) * | 2006-10-13 | 2009-12-16 | 利莱恩斯生命科学有限公司 | 生物聚合物上的培养黑素细胞 |
| EA013133B1 (ru) * | 2008-12-26 | 2010-02-26 | Некоммерческое Учреждение "Научно-Исследовательский Институт Цитохимии И Молекулярной Фармакологии" | Композиция аминокислот подъязычного применения для повышения репигментации кожного покрова при витилиго и способ ее применения |
| RU2405560C1 (ru) * | 2009-05-29 | 2010-12-10 | Общество С Ограниченной Ответственностью "Медицинский Исследовательский Центр "Иммункулус" | Средство для защиты клеток мозга |
| CN102266586B (zh) * | 2011-06-28 | 2013-12-04 | 江苏省人民医院 | 白癜风黑素细胞移植涂布载体系统的制备方法 |
| FR3051204B1 (fr) | 2016-05-10 | 2018-05-04 | Rkm | Engin roulant, notamment pour la depose au sol, sous forme d’un lit, de materiaux en vrac |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE454745B (sv) * | 1982-12-10 | 1988-05-30 | Cubana Importadora Y Exportado | Produkt for att stimulera syntesen av melanotiskt pigment i huden vid botande av vigiligo |
| US4507277A (en) * | 1983-04-08 | 1985-03-26 | Empresa Cubana Importadora Y Exportadora De Productos Medicos | Composition and method for stimulating the synthesis of the melanotic pigment of the skin |
| RU2040263C1 (ru) * | 1992-01-17 | 1995-07-25 | Научно-исследовательский институт текстильных материалов | Способ получения меланина |
| RU2083214C1 (ru) * | 1993-04-23 | 1997-07-10 | Голоунин Александр Васильевич | Способ получения меланина |
| CA2250000C (en) * | 1996-03-28 | 2010-06-15 | Trustees Of Boston University | Methods of modulating melanin synthesis |
| US5690966A (en) * | 1996-10-17 | 1997-11-25 | Council Of Scientific & Industrial Research | Process for the preparation of an extract from human placenta containing glycosphingolipids and endothelin-like constituent peptides useful for the treatment of vitiligo |
| US6451358B2 (en) * | 1999-12-29 | 2002-09-17 | Mileuna, Inc. | Composition and method for the treatment of vitiligo |
-
1998
- 1998-07-28 CU CU1998110A patent/CU22695A1/es unknown
-
1999
- 1999-07-27 AR ARP990103684A patent/AR029307A1/es unknown
- 1999-07-28 US US09/744,633 patent/US6660305B1/en not_active Expired - Lifetime
- 1999-07-28 BR BR9913345-8A patent/BR9913345A/pt not_active IP Right Cessation
- 1999-07-28 CA CA002336526A patent/CA2336526A1/en not_active Abandoned
- 1999-07-28 MX MXPA01001014A patent/MXPA01001014A/es active IP Right Grant
- 1999-07-28 WO PCT/CU1999/000003 patent/WO2000006180A1/es not_active Ceased
- 1999-07-28 AT AT99934451T patent/ATE284699T1/de not_active IP Right Cessation
- 1999-07-28 EP EP99934451A patent/EP1101494B1/en not_active Expired - Lifetime
- 1999-07-28 HU HU0103274A patent/HUP0103274A2/hu unknown
- 1999-07-28 CN CNB99810745XA patent/CN1187059C/zh not_active Expired - Fee Related
- 1999-07-28 DE DE69922662T patent/DE69922662D1/de not_active Expired - Lifetime
- 1999-07-28 UA UA2001010624A patent/UA63015C2/uk unknown
- 1999-07-28 JP JP2000562034A patent/JP2002521453A/ja active Pending
- 1999-07-28 RU RU2001105539/15A patent/RU2225716C2/ru not_active IP Right Cessation
-
2001
- 2001-01-31 BG BG105208A patent/BG105208A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| UA63015C2 (en) | 2004-01-15 |
| EP1101494B1 (en) | 2004-12-15 |
| WO2000006180A1 (es) | 2000-02-10 |
| DE69922662D1 (de) | 2005-01-20 |
| MXPA01001014A (es) | 2002-06-04 |
| ATE284699T1 (de) | 2005-01-15 |
| HK1037520A1 (en) | 2002-02-15 |
| CA2336526A1 (en) | 2000-02-10 |
| US6660305B1 (en) | 2003-12-09 |
| CN1187059C (zh) | 2005-02-02 |
| EP1101494A1 (en) | 2001-05-23 |
| JP2002521453A (ja) | 2002-07-16 |
| RU2225716C2 (ru) | 2004-03-20 |
| BG105208A (en) | 2001-07-31 |
| AR029307A1 (es) | 2003-06-25 |
| CN1316905A (zh) | 2001-10-10 |
| BR9913345A (pt) | 2001-10-16 |
| HUP0103274A2 (hu) | 2002-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Cohen et al. | Cutaneous interaction with visible light: What do we know? | |
| CY1123579T1 (el) | Φαρμακευτικα σκευασματα με βαση λιπιδια για τοπικη εφαρμογη | |
| US20110020252A1 (en) | Method of long lasting human skin tanning | |
| BRPI0517500B8 (pt) | composto, uso de uma composição, composição farmacêutica, composição cosmética, usos não-terapêuticos de uma composição cosmética e processo cosmético para melhorar a aparência da pele | |
| US8911774B2 (en) | Topical composition for anti-aging skin treatment using dual DNA repair mechanism and method of use | |
| AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
| JP2018507740A (ja) | 光線療法を使用してスキンケアを提供する方法 | |
| ATE97316T1 (de) | Kosmetisches mittel und zusammensetzung zur behandlung der haut. | |
| Pawar et al. | Sida cordifolia Linn. accelerates wound healing process in type 2 diabetic rats | |
| CU22695A1 (es) | Formulación para la estimulación de la síntesis del pigmento melánico | |
| Wong et al. | Silicone cream occlusive dressing–a novel noninvasive regimen in the treatment of keloid | |
| US9968546B2 (en) | Topical composition for skin treatment to reduce lines and wrinkles of the face and body using a dual DNA repair mechanism to address damage caused by aging and ultra-violet induced damage to the skin with combination of skin turgor enhancement compounds | |
| Ibsen et al. | Differences among tetracyclines with respect to the staining of teeth | |
| Fabricius et al. | The relation between methyl aminolevulinate concentration and inflammation after photodynamic therapy in healthy volunteers | |
| Shah et al. | Trichofolliculoma–'troll hair'dermoscopy. | |
| KR101282280B1 (ko) | 리놀렌산을 유효성분으로 포함하는 백반증 치료용 의약적 조성물 | |
| US20180280266A1 (en) | Xanthophyll compositions for skin lightening | |
| CU22693A1 (es) | Composición para el tratamiento de la psoriasis y método para su obtención | |
| Ha et al. | Exploring the skin whitening properties of natural products: A comprehensive review | |
| Kausar et al. | Evaluation of depegmenting and antierythemic effects of cosmetic emulgels containing raspberry fruit extract on human cheek skin | |
| Lyebyedyeva et al. | Removal of hyperpigmentation. Evaluation of the efficacy of treatments with tranexamic acid and vitamin C-case report. | |
| MX2021015351A (es) | Formulaciones para uso odontologico y dermatologico que contienen sales de tricloroacetato e hidroxiacidos. | |
| Sjerobabski Masnec et al. | Photorejuvenation–topical photodynamic therapy as therapeutic opportunity for skin rejuvenation | |
| Mohite et al. | Formulation and Evaluation of Herbal Based Nail Polish | |
| Adhikari et al. | A comparative study between the use of the combination of trichloroacetic acid peeling with hydroquinone and hydroquinone alone in patients with melasma |